Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma.

Popovic, Maja; Matovina-Brko, Gorana; Jovic, Masa; Popovic, Lazar S

Popovic, Maja; Matovina-Brko, Gorana; Jovic, Masa; Popovic, Lazar S.

Afiliação

Popovic M; Department of Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, Sremska Kamenica 21204, Serbia.
Matovina-Brko G; Department of Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, Sremska Kamenica 21204, Serbia.
Jovic M; Department of Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, Sremska Kamenica 21204, Serbia.
Popovic LS; Department of Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, Sremska Kamenica 21204, Serbia.

World J Clin Oncol ; 13(1): 28-38, 2022 Jan 24.

Article em En | MEDLINE | ID: mdl-35116230

Palavras-chave

Biomarkers; Checkpoint inhibitors; Immunotherapy; Programmed cell death 1 receptor; Renal cell carcinoma; Tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: World J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google